FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Chlordiazepoxide Hydrochloride Capsules
Status: Currently in Shortage
»Date first posted: 03/30/2021
»Therapeutic Categories: Neurology; Psychiatry

Expand all

Epic Pharma, LLC (New 06/21/2021)

Company Contact Information:
609-955-4922

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10mg, 100ct (NDC 42806-562-01) Available
25mg, 100ct (NDC 42806-563-01) Available

Teva Pharmaceuticals (Revised 09/20/2021)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg, 1000 count (NDC 0555-0033-05) Currently unavailable. Expected resupply end of August and product recovery by September, 2021 Regulatory delay
10 mg, 100 count (NDC 0555-0033-02) Expected product recovery September 2021 Regulatory delay
25 mg, 100 count (NDC 0555-0159-02) Currently unavailable. Expected resupply and product recovery September, 2021 Regulatory delay
5 mg, 500 count (NDC 0555-0158-04) Expected product recovery September 2021 Regulatory Delay
25 mg, 500 count (NDC 0555-0159-04) Currently unavailable. Resupply end of September 2021 and product recovery October 2021. Regulatory Delay
5 mg, 100 count (NDC 0555-0158-02) Expected product recovery September 2021 Regulatory Delay

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English